SCHEMBL540970

SCHEMBL540970

Oc1ccccn1.[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29419423 0.97
SCHEMBL18660488 0.97
SCHEMBL8978433 0.97 KDM4E (0.50)
SCHEMBL2355 0.97
Benzene SCHEMBL28342353 0.94 LMNA (0.48)
Hydrochloric Acid SCHEMBL1868855 0.94
SCHEMBL1146004 0.94
SCHEMBL8504418 0.94
SCHEMBL7209441 0.94
Water SCHEMBL7171316 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8898047-B2 Methods for identifying inhibitors against viruses that use a class I fusion protein JANSSEN PHARMACEUTICALS NV (BE) 2014-11-25 US claimed
EP-2257809-B1 METHOD FOR IDENTIFYING INHIBITORS AGAINST VIRUSES THAT USE A CLASS I FUSION PROTEIN TIBOTEC PHARM LTD (IE) 2012-02-08 EP claimed
US-20110009408-A1 METHODS FOR IDENTIFIYING INHIBITORS AGAINST VIRUSES THAT USE A CLASS I FUSION PROTEIN JANSSEN SCIENCES IRELAND UC (IE) 2011-01-13 US claimed
CN-114478372-A Asymmetric preparation method of pyridinol nitrogen oxide 凯特立斯(深圳)科技有限公司 2022-05-13 CN disclosed
CN-114478372-A Asymmetric preparation method of pyridinol nitrogen oxide 凯特立斯(深圳)科技有限公司 2022-05-13 CN disclosed
CN-114478372-A Asymmetric preparation method of pyridinol nitrogen oxide 凯特立斯(深圳)科技有限公司 2022-05-13 CN disclosed
US-8898047-B2 Methods for identifying inhibitors against viruses that use a class I fusion protein JANSSEN PHARMACEUTICALS NV (BE) 2014-11-25 US disclosed
EP-2257809-B1 METHOD FOR IDENTIFYING INHIBITORS AGAINST VIRUSES THAT USE A CLASS I FUSION PROTEIN TIBOTEC PHARM LTD (IE) 2012-02-08 EP disclosed
US-20110009408-A1 METHODS FOR IDENTIFIYING INHIBITORS AGAINST VIRUSES THAT USE A CLASS I FUSION PROTEIN JANSSEN SCIENCES IRELAND UC (IE) 2011-01-13 US disclosed